3 results
A Randomized, Double-Blind, Placebo-Controlled, Flexible Dose Phase 2 Study of Efficacy and Safety of Tirzepatide in Individuals with Alcohol Use Disorder and Metabolic Alcohol-associated Liver Disease
The National Institutes of Health (NIH) is conducting a research study to explore whether an investigational GLP1 medication called Tirzepatide can help people improve liver health. This study focuses on individuals who are overweight and drink alcohol regularly.
Unit and Clinic Evaluation, Screening, Assessment, and Management
If you or someone you know is drinking too much, the National Institutes of Health (NIH) may be able to help. We conduct studies on how alcohol affects the body and are looking for new ways to treat alcohol problems. If you qualify, you can receive alcoholism treatment at no-cost while you participate in our research.
Learn More